RNS Number:9096B
Hikma Pharmaceuticals Plc
25 April 2006



                Hikma to list Global Depositary Receipts on DIFX

LONDON, 25 April 2006 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK), the
multinational pharmaceuticals group, will tomorrow list Global Depository
Receipts ("GDRs") on the Dubai International Financial Exchange ("DIFX").

The listing follows Hikma's initial public offering (the "IPO") of ordinary
shares on the London Stock Exchange in November 2005. This is a secondary
listing of existing shares and each GDR will represent two ordinary shares.

Samih Darwazah, Chairman and Chief Executive of Hikma, said: "We are very
pleased to announce the listing of our GDRs on the DIFX, in line with our stated
intention at the time of our IPO. Through this listing, we hope to reinforce our
strong profile in our Middle East and North Africa markets and to gain better
access to the diverse Middle East investor base."

                                    - ENDS -

Enquiries:

Hikma Pharmaceuticals PLC

Susan Ringdal                                                +44 20 7479 4893
Investor Relations Director

Brunswick Group

Jon Coles / Wendel Verbeek / Justine McIlroy / Alex Tweed    +44 20 7404 5959

About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the United States,
the Middle East and North Africa ("MENA") region and Europe. In 2005, the Group
had revenue of $262 million and profit attributable to shareholders of $44
million. At 31 December 2005, the Group had over 1,800 employees. For news and
other information, please visit www.hikma.com.

About DIFX
The DIFX is the region's first international financial exchange for equities,
bonds, Islamic products, funds, index products and (subject to regulatory
approval) derivatives. The target areas of the DIFX for seeking issuers include
the Middle East and North Africa, as well as South Africa, Turkey and the Indian
sub-continent. The exchange launched in September 2005 and currently has 12
Member banks. The regulator of the DIFX is the Dubai Financial Services
Authority. The DIFX is located in the Dubai International Financial Centre
(DIFC) and its owner is the DIFC Authority. The trading hours of the DIFX are
from 11:45am to 5pm (07:45am to 1pm GMT) from Monday to Friday. www.difx.ae




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCEAXLLAELKEFE
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.